Cardiovascular event risk estimated by myocardial perfusion SPECT combined with clinical data

Tomohiko Sakatani; Kenichi Nakajima; Tsunehiko Nishimura

doi:10.1016/j.jjcc.2021.10.004

Cardiovascular event risk estimated by myocardial perfusion SPECT combined with clinical data

J Cardiol. 2022 Jul;80(1):64-71. doi: 10.1016/j.jjcc.2021.10.004. Epub 2021 Oct 30.

Authors

Tomohiko Sakatani¹, Kenichi Nakajima², Tsunehiko Nishimura³

Affiliations

¹ Department of Cardiology, Osaka General Hospital of West Japan Railway Company, Osaka, Japan. Electronic address: [email protected].
² Department of Functional Imaging and Artificial Intelligence, Kanazawa University, Kanazawa, Japan.
³ Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

PMID: 34728122
DOI: 10.1016/j.jjcc.2021.10.004

Abstract

Myocardial scintigraphy plays important roles in the diagnosis of coronary artery disease, prognostic risk stratification, and determination of the treatment policy. Recently, several large-scale clinical trials reported that coronary intervention was not necessarily advantageous for preventing future cardiac events in patients with stable angina. This review summarizes how we can estimate cardiac event risks based on Japanese Assessment of Cardiac Events and Survival Study by Quantitative Gated SPECT (J-ACCESS), and describes that the combination of scintigraphy and other clinical features leads to more accurate stratification of prognosis and the determination of subsequent treatment policy.

Keywords: Cardiac risk model; Coronary artery disease; Coronary intervention; Scintigraphy.

Publication types

Review

MeSH terms

Coronary Artery Disease* / therapy
Humans
Myocardial Perfusion Imaging* / methods
Perfusion
Prognosis
Risk Assessment / methods
Tomography, Emission-Computed, Single-Photon / methods